Clinical significance and antifungal susceptibility profile of 103 clinical isolates of <i>Scedosporium</i> species complex and <i>Lomentospora prolificans</i> obtained from NIH patients. [PDF]
Czech MM +12 more
europepmc +1 more source
Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients [PDF]
core +1 more source
Review of the novel antifungal drug olorofim (F901318). [PDF]
Vanbiervliet Y +5 more
europepmc +1 more source
Update on therapeutic approaches for invasive fungal infections in adults. [PDF]
Boutin CA, Luong ML.
europepmc +1 more source
Scedosporiosis presenting with subcutaneous nodules in an immunocompromised patient
Jisu Chen, Honghua Hu
openaire +1 more source
Scedosporium infection as a late complication after start of elexacaftor/tezacaftor/ivacaftor: two case reports. [PDF]
van Mourik P +6 more
europepmc +1 more source
<i>Scedosporium apiospermum</i>-induced brain abscess leading to rapid mortality in an immunocompetent adult male from Uttarakhand, India. [PDF]
Singh M, Anand P, Perumalla S, Prasad A.
europepmc +1 more source
Masquerading Yeast: A Case Report of <i>Lomentospora prolificans</i> Fungemia With a Diagnostic Twist. [PDF]
Fenlon LA, Swaminathan N.
europepmc +1 more source
Fosmanogepix for the Treatment of Invasive Mold Diseases Caused by Aspergillus Species and Rare Molds: A Phase 2, Open-Label Study (AEGIS). [PDF]
Hodges MR +11 more
europepmc +1 more source

